Call: (+91) 73979 11126
Name : Boldarix Composition : Boldenone Undecylenate Strength : 250mg/ml Manufactured by : Matrix Biolabs Form : Injection Packing : 10 Ampolues of 1 ml
Boldarix (Boldenone Undecylenate (BLD) is a synthetic derivative of testosterone and a widely used anabolic androgenic steroid. The health risk of using BLD as a pharmaceutical or dietary supplement is still underestimated.
Boldarix (boldenone Undecylenate) (Equipoise) Boldenone is an anabolic androgenic steroid, and synthetic derivative of testosterone initially developed for veterinary use. Still, it has since become one of the most common performance-enhancing drugs that athletes test positive for sports.
With a chemical structure almost identical to testosterone, Boldenone can stimulate protein synthesis and the release of erythropoietin in the kidneys. Athletes sometimes use Boldenone, which can be sold on the black market, to increase muscle mass and strength.
In addition to being banned from sports, athletes should be aware of the numerous health and safety concerns associated with Boldenone.
After completing the entire Boldenone Undecylenate cycle, acne can develop on your back, shoulders, or chest. An increase in blood cholesterol is also likely. In rare cases, baldness or enlarged prostate occurs. To avoid these adverse effects, it is necessary to correctly select the dose of the drug, also taking into account the characteristics of the physical type.
Product Enquiry
Select you countryAfghanistanAlbaniaAlgeriaAndorraAngolaAntigua and BarbudaArgentinaArmeniaAustraliaAustriaAzerbaijanThe BahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBhutanBoliviaBosnia and HerzegovinaBotswanaBrazilBruneiBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCentral African RepublicChadChileChinaColombiaComorosCongoCosta RicaCroatiaCubaCyprusCzech RepublicDenmarkDjiboutiDominicaDominican RepublicEast TimorEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFijiFinlandFranceGabonThe GambiaGeorgiaGermanyGhanaGreeceGrenadaGuatemalaGuineaGuinea-BissauGuyanaHaitiHondurasHungaryIcelandIndiaIndonesiaIranIraqIrelandIsraelItalyamaicaJapanJordanKazakhstanKenyaKiribatiKorea, NorthKorea, SouthKosovoKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMauritaniaMauritiusMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew ZealandNicaraguaNigerNigeriaNorth MacedoniaNorwayOmanPakistanPalauPanamaPapua New GuineaParaguayPeruPhilippinesPolandPortugalQatarRomaniaRussiaRwandaSaint Kitts and NevisSaint LuciaSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSpainSri LankaSudanSudan, SouthSurinameSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTogoTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTuvaluUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVatican CityVenezuelaVietnamYemenZambiaZimbabwe
Log in